期刊文献+

基于铁死亡与染色质修饰途径探讨中医药在神经系统疾病中的调控研究进展

To explore the regulation of traditional Chinese medicine against nervous system diseases based on ferroptosis and chromatin modification
下载PDF
导出
摘要 随着人口老龄化的加速,阿尔兹海默病、帕金森病、抑郁症等神经系统疾病不仅对患者的身心健康造成影响,更为家庭和社会带来很大负担。近年来研究发现铁死亡与神经系统疾病关系密切,而染色质修饰可影响铁死亡的发生发展过程。中医药治疗神经系统疾病具有多靶点、多途径等优势,基于染色质修饰介导铁死亡来探索中医药对于神经系统疾病的调控机制将成为研究中医药治疗神经系统疾病的新方向。文章通过阐述铁死亡与染色质修饰途径之间的相互作用,为中医药治疗神经系统疾病研发提供理论基础。 As the aging population grows,Alzheimer's disease(AD),Parkinson's disease(PD),depression(MDD)and other neurological diseases not only affect physical and mental health,but also bring a great burden to the family and society.In recent years,studies have found that ferroptosis is closely related to nervous system diseases,and chromatin modification can affect the progressof ferroptosis.Traditional Chinese medicine has the advantages of multiple targets and multiple pathways in the treatment of nervous system diseases.Exploring the regulatory mechanism of traditional Chinese medicine on nervous system diseases based on chromatin modification-mediated ferroptosis will become a new direction of research on the treatment of nervous system diseases by traditional Chinese medicine.This article reviewed the interaction between ferroptosis and chromatin modification to provide a theoretical basis for the research and development of traditional Chinese medicine in the treatment of neurological diseases.
作者 姜波 牛梦琦 刘金雨(综述) 李宝龙(审校) JIANG Bo;NIU Mengqi;LIU Jinyu reviewing;LI Baolong checking(School of Basic Medicine,Heilongjiang University of Chinese Medicine,Harbin 150040,Heilongjiang,China)
出处 《医学研究与战创伤救治》 CAS 北大核心 2023年第6期661-666,共6页 Journal of Medical Research & Combat Trauma Care
基金 黑龙江省自然科学基金(LH2019H049)。
关键词 铁死亡 染色质修饰 中医药 神经系统疾病 ferroptosis chromatin modification traditional Chinese medicine neurological diseases
  • 相关文献

参考文献2

二级参考文献213

  • 1Goldknopf IL, French MF, Musso R, Busch H. Presence of protein A24 in rat liver nucleosomes. Proc Natl Acad Sci USA 1977; 74:5492-5495.
  • 2Cohen P. The origins of protein phosphorylation. Nat Cell Biol 2002; 4:E127-EI30.
  • 3Verdin E, Ott M. 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond. Nat Rev Mol Cell Biol 2015; 16:258-264.
  • 4Hershko A, Ciechanover A. The ubiquitin system. Annu RevBiochem 1998; 67:425-479.
  • 5Clague M J, Heride C, U"be S. The demographics of the ubiq- uitin system. D'ends Cell Biol 2015; 25:417-426.
  • 6Pickart CM. Mechanisms underlying ubiquitination. Anntl Rev Biochem 2001; 70:503-533.
  • 7Schulman BA, Harper JW. Ubiquitin-like protein activation by E1 enzymes: the apex fo," downstream signaling pathways. Vat Rev .~ol Cell Biol 2009:10:319-331.
  • 8Ye Y, Rape M. Building ubiquitin chains: E2 enzymes at work. Nat Rev Mol Cell Bio12009; 10:755-764.
  • 9Deshaies R J, Joazeiro CAP. RING domain E3 ubiquitin ligas- es. Annu Rev Biochem 2009; 78:399-434.
  • 10Smit J J, Sixma TK. RBR E3-1igases at work. EMBO Rep 2014: 15:142-154.

共引文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部